Business Description
Masimo Corp
NAICS : 339112
SIC : 5047
ISIN : BRM2ASBDR009
Share Class Description:
BSP:M2AS34: BRDRTotal Employee Number:
2,200Description
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 1.41 | |||||
Interest Coverage | 10.11 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 9.77 | |||||
Beneish M-Score | -3.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.6 | |||||
3-Year EBITDA Growth Rate | -0.4 | |||||
3-Year EPS without NRI Growth Rate | -4.7 | |||||
3-Year Book Growth Rate | -18.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.92 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.99 | |||||
9-Day RSI | 99.75 | |||||
14-Day RSI | 98.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.68 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.38 | |||||
Days Inventory | 212.77 | |||||
Days Sales Outstanding | 61.81 | |||||
Days Payable | 69.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 5.82 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.73 | |||||
Operating Margin % | 19.86 | |||||
Net Margin % | 4.9 | |||||
EBITDA Margin % | 22.11 | |||||
FCF Margin % | 13.28 | |||||
OCF Margin % | 14.94 | |||||
ROE % | 8.85 | |||||
ROA % | 3.87 | |||||
ROIC % | 15.6 | |||||
3-Year ROIIC % | -6.73 | |||||
ROC (Joel Greenblatt) % | 40.03 | |||||
ROCE % | 20.01 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 128.54 | |||||
Forward PE Ratio | 1 | |||||
PE Ratio without NRI | 38.92 | |||||
Shiller PE Ratio | 69.36 | |||||
PS Ratio | 6.18 | |||||
PB Ratio | 11.94 | |||||
Price-to-Tangible-Book | 14.77 | |||||
Price-to-Free-Cash-Flow | 46.91 | |||||
Price-to-Operating-Cash-Flow | 41.66 | |||||
EV-to-EBIT | 31.96 | |||||
EV-to-EBITDA | 28.4 | |||||
EV-to-Revenue | 6.28 | |||||
EV-to-FCF | 47.48 | |||||
Price-to-GF-Value | 1.06 | |||||
Price-to-Projected-FCF | 5.3 | |||||
Price-to-Median-PS-Value | 0.94 | |||||
Price-to-Graham-Number | 5.06 | |||||
| Price-to-Net-Current-Asset-Value | 557.14 | |||||
Earnings Yield (Greenblatt) % | 3.13 | |||||
FCF Yield % | 2.19 | |||||
Forward Rate of Return (Yacktman) % | -7.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Masimo Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 8,410.434 | ||
| EPS (TTM) (R$) | 7.649 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 98.88 | ||
| 14-Day ATR (R$) | 0.668806 | ||
| 20-Day SMA (R$) | 30.1865 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (R$) | 29.67 - 39 | ||
| Shares Outstanding (Mil) | 52.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Masimo Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Masimo Corp Stock Events
| Event | Date | Price (R$) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 16:30 | In 132 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 131 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 16:30 | In 41 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 40 days | ||
| General meeting for 2026 | 2026-06-16 08:00 | 30.67 (+0.00%) | ||
| First quarter earnings results for 2027 | 2026-05-05 | 29.67 (+0.00%) | ||
| Annual report for 2025 | 2026-02-27 | -- | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 16:30 | -- | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | -- | ||
| Guidance call for 2026 | 2026-01-14 14:15 | -- |
Show
Entries
Masimo Corp Frequently Asked Questions
What is Masimo Corp(BSP:M2AS34)'s stock price today?
The current price of BSP:M2AS34 is R$39.00. The 52 week high of BSP:M2AS34 is R$39.00 and 52 week low is R$29.67.
When is next earnings date of Masimo Corp(BSP:M2AS34)?
The next earnings date of Masimo Corp(BSP:M2AS34) is 2026-08-05 Est..
Does Masimo Corp(BSP:M2AS34) pay dividends? If so, how much?
Masimo Corp(BSP:M2AS34) does not pay dividend.
Press Release
Articles on Masimo Corp
No articles.